Xuan Huang1, Robert J Gillies, Haibin Tian. 1. Department of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Abstract
To synthesize (18) F-labeled positron emission tomography (PET) ligands, reliable labeling techniques inserting (18) F into a target molecule are necessary. The (18) F-fluorobenzene moiety has been widely utilized in the synthesis of (18) F-labeled compounds. The present study utilized [(18) F]-labeled aniline as intermediate in [(18) F]-radiolabeling chemistry for the facile radiosynthesis of 4-amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide ([(18) F]IDO5L) as indoleamine 2,3-dioxygenase 1 (IDO1) targeted tracer. IDO5L is a highly potent inhibitor of IDO1 with low nanomolar IC50 . [(18) F]IDO5L was synthesized via coupling [(18) F]3-chloro-4-fluoroaniline with carboximidamidoyl chloride as a potential PET probe for imaging IDO1 expression. Under the optimized labeling conditions, chemically and radiochemically pure (>98%) [(18) F]IDO5L was obtained with specific radioactivity ranging from 11 to 15 GBq/µmol at the end of synthesis within ~90 min, and the decay-corrected radiochemical yield was 18.2 ± 2.1% (n = 4).
To synthesize (18) F-labeled positron emission tomography (PET) ligands, reliable labeling techniques inserting (18) F into a target molecule are necessary. The (18) F-fluorobenzene moiety has been widely utilized in the synthesis of (18) F-labeled compounds. The present study utilized [(18) F]-labeled n class="Chemical">aniline as intermediate in [(18) F]-radiolabeling chemistry for the facile radiosynthesis of 4-amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide ([(18) F]IDO5L) as indoleamine 2,3-dioxygenase 1 (IDO1) targeted tracer. IDO5L is a highly potent inhibitor of IDO1 with low nanomolar IC50 . [(18) F]IDO5L was synthesized via coupling [(18) F]3-chloro-4-fluoroaniline with carboximidamidoyl chloride as a potential PET probe for imaging IDO1 expression. Under the optimized labeling conditions, chemically and radiochemically pure (>98%) [(18) F]IDO5L was obtained with specific radioactivity ranging from 11 to 15 GBq/µmol at the end of synthesis within ~90 min, and the decay-corrected radiochemical yield was 18.2 ± 2.1% (n = 4).
Authors: Alexander J Muller; James B DuHadaway; P Scott Donover; Erika Sutanto-Ward; George C Prendergast Journal: Nat Med Date: 2005-02-13 Impact factor: 53.440
Authors: Maria Friberg; Ronald Jennings; Marwan Alsarraj; Sophie Dessureault; Alan Cantor; Martine Extermann; Andrew L Mellor; David H Munn; Scott J Antonia Journal: Int J Cancer Date: 2002-09-10 Impact factor: 7.396
Authors: Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde Journal: Nat Med Date: 2003-09-21 Impact factor: 53.440
Authors: Vesa Lindström; Janne Aittoniemi; Juulia Jylhävä; Carita Eklund; Mikko Hurme; Timo Paavonen; Simo S Oja; Maija Itälä-Remes; Marjatta Sinisalo Journal: Clin Lymphoma Myeloma Leuk Date: 2012-09-13
Authors: Csaba Juhász; Otto Muzik; Xin Lu; M Salik Jahania; Ayman O Soubani; Majid Khalaf; Fangyu Peng; Thomas J Mangner; Pulak K Chakraborty; Diane C Chugani Journal: J Nucl Med Date: 2009-02-17 Impact factor: 10.057
Authors: Carlos E A Batista; Csaba Juhász; Otto Muzik; William J Kupsky; Geoffrey Barger; Harry T Chugani; Sandeep Mittal; Sandeep Sood; Pulak K Chakraborty; Diane C Chugani Journal: Mol Imaging Biol Date: 2009-05-12 Impact factor: 3.488
Authors: Eddy W Yue; Brent Douty; Brian Wayland; Michael Bower; Xiangdong Liu; Lynn Leffet; Qian Wang; Kevin J Bowman; Michael J Hansbury; Changnian Liu; Min Wei; Yanlong Li; Richard Wynn; Timothy C Burn; Holly K Koblish; Jordan S Fridman; Brian Metcalf; Peggy A Scherle; Andrew P Combs Journal: J Med Chem Date: 2009-12-10 Impact factor: 7.446
Authors: Anthony F Shields; Paula M Jacobs; Mario Sznol; Michael M Graham; Ron N Germain; Lawrence G Lum; Elizabeth M Jaffee; Elisabeth G E de Vries; Sridhar Nimmagadda; Annick D Van den Abbeele; David K Leung; Anna M Wu; Elad Sharon; Lalitha K Shankar Journal: J Nucl Med Date: 2017-08-17 Impact factor: 10.057
Authors: Edit Bosnyák; David O Kamson; Anthony R Guastella; Kaushik Varadarajan; Natasha L Robinette; William J Kupsky; Otto Muzik; Sharon K Michelhaugh; Sandeep Mittal; Csaba Juhász Journal: Neuro Oncol Date: 2015-06-18 Impact factor: 12.300
Authors: Edit Bosnyák; David O Kamson; Michael E Behen; Geoffrey R Barger; Sandeep Mittal; Csaba Juhász Journal: EJNMMI Res Date: 2015-10-17 Impact factor: 3.138